Lee, Dean A <br/><br/>
EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH.  [electronic resource] 

 -  Pediatric blood & cancer  Mar 2008 
 - 728-30 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.21121  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Asparaginase--administration & dosage<br/>Cytarabine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Therapy, Combination<br/>Epstein-Barr Virus Infections--complications<br/>Fatal Outcome<br/>Female<br/>Herpesvirus 4, Human--physiology<br/>Histiocytosis, Langerhans-Cell--complications<br/>Humans<br/>Immunocompromised Host<br/>Infant<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Mercaptopurine--administration & dosage<br/>Methotrexate--administration & dosage<br/>Mycoses--etiology<br/>Prednisone--administration & dosage<br/>Recurrence<br/>Rituximab<br/>Vinblastine--administration & dosage<br/>Vincristine--administration & dosage<br/>Virus Activation